4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 78.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 190.00
  • 52 Week Low: 76.00
  • Currency: UK Pounds
  • Shares Issued: 65.49m
  • Volume: 0
  • Market Cap: £51.09m

Latest Deals

Traded Action Notifier PriceAmountValue
29-May-19 Buy David Robert Norwood 100.00p 15,000 £15,000.00
22-May-19 Buy Duncan Joseph Peyton 105.00p 9,891 £10,385.55
21-May-19 Buy Alexander James Stevenson 98.00p 50,998 £49,978.04
21-May-19 Buy Duncan Joseph Peyton 99.40p 101,199 £100,591.81
21-May-19 Buy David Robert Norwood 96.00p 5,000 £4,800.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
12-Dec-18 Buy Duncan Joseph Peyton 120.00p 86,929 £104,314.80
21-May-19 Buy Duncan Joseph Peyton 99.40p 101,199 £100,591.81
12-Dec-18 Buy Alexander James Stevenson 115.00p 86,956 £99,999.40
12-Dec-18 Buy David Robert Norwood 114.00p 50,000 £57,000.00
21-May-19 Buy Alexander James Stevenson 98.00p 50,998 £49,978.04

Director Shareholdings

Notifier Holding Value*
David Robert Norwood 7,123,725 £5,556,506
Duncan Joseph Peyton 6,455,075 £5,034,958
Alexander James Stevenson 6,413,136 £5,002,246
Thomas Engelen 523,800 £408,564

Major Shareholders

Notifier** Holding Value*
Woodford Investment Management LLP 15,771,110 £12,301,466
Invesco Limited 9,163,617 £7,147,621
Janus Henderson Group plc 3,425,648 £2,672,005
Lansdowne Partners 3,000,000 £2,340,000

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4D Pharma Market Data

Currency UK Pounds
Share Price 78.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 190.00
52 Week Low 76.00
Volume 0
Shares Issued 65.49m
Market Cap £51.09m

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
1.74% above the market average1.74% above the market average1.74% above the market average1.74% above the market average1.74% above the market average
8.47% below the sector average8.47% below the sector average8.47% below the sector average8.47% below the sector average8.47% below the sector average
Price Trend
84.87% below the market average84.87% below the market average84.87% below the market average84.87% below the market average84.87% below the market average
70% below the sector average70% below the sector average70% below the sector average70% below the sector average70% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

4D Pharma Dividends

No dividends found

Trades for --2019

Time Volume / Share Price
0 @ 0.000p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page